INVEGA
paliperidone
- Strength
- 9 mg/1
- Form
- Tablet, Extended Release
- Class
- Atypical Antipsychotic
Janssen Pharmaceuticals, Inc.
Paliperidone
Listed by NorthStar RxLLC
- Strength
- 9 mg/1
- Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Class
- Atypical Antipsychotic
What it contains
- Paliperidone 9 mg/1
FDA record
| Dosage form | Tablet, Film Coated, Extended Release |
|---|---|
| Route | Oral |
| Drug class | Atypical Antipsychotic |
| Approval route | ANDA — approved generic |
| NDC code | 16714-869 |
| FDA application | ANDA205618 |
| RxNorm concept | 672567 |
| Package sizes listed | 1 |
| Marketed since | October 2018 |
Other products containing Paliperidone
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
INVEGA
paliperidone
- Strength
- 1.5 mg/1
- Form
- Tablet, Extended Release
- Class
- Atypical Antipsychotic
Janssen Pharmaceuticals, Inc.
INVEGA
paliperidone
- Strength
- 3 mg/1
- Form
- Tablet, Extended Release
- Class
- Atypical Antipsychotic
Janssen Pharmaceuticals, Inc.
INVEGA
paliperidone
- Strength
- 6 mg/1
- Form
- Tablet, Extended Release
- Class
- Atypical Antipsychotic
Janssen Pharmaceuticals, Inc.
Paliperidone
- Strength
- 6 mg/1
- Form
- Tablet, Extended Release
- Class
- Atypical Antipsychotic
Bryant Ranch Prepack
PALIPERIDONE
- Strength
- 9 mg/1
- Form
- Tablet, Extended Release
- Class
- Atypical Antipsychotic
Eskayef Pharmaceuticals Limited
Paliperidone
- Strength
- 3 mg/1
- Form
- Tablet, Film Coated, Extended Release
- Class
- Atypical Antipsychotic
Archis Pharma LLC
Paliperidone
- Strength
- 6 mg/1
- Form
- Tablet, Film Coated, Extended Release
- Class
- Atypical Antipsychotic
Archis Pharma LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.